Clinical Trials Logo
  1. Home
  2. Platelet Aggregation
  3. NCT00233428
  4. Details
NCT00233428 Clinical Trial

Study to Determine Racial and Gender Differences in Platelet Aggregation

Platelet Aggregation Clinical Trial

Official title:
Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00233428
Other study ID # L05-108
Secondary ID
Status Completed
Phase Phase 1
First received October 3, 2005
Last updated May 11, 2015
Start date May 2005
Est. completion date May 2006

Study information
Verified date May 2015
Source Texas Tech University Health Sciences Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Description:

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.

We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

Recruitment information / eligibility
Status Completed
Enrollment 60
Est. completion date May 2006
Est. primary completion date May 2006
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Race of Caucasian, African American, or Hispanic

Exclusion Criteria:

- Chronic medical conditions

- Tobacco use

- Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Procedure:
• Blood Draw

Locations
Country Name City State
United States TTUHSC Lubbock Texas

Sponsors (1)
Lead Sponsor Collaborator
Texas Tech University Health Sciences Center

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT04492423 - VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT02958657 - Effect of Exercise on Platelet Reactivity After Myocardial Infarction N/A
Completed NCT01815008 - Pharmacogenomics of Antiplatelet Response - I Phase 4
Completed NCT03039205 - Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor Phase 2
Completed NCT01557335 - A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540 Phase 1
Completed NCT05581238 - Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
Completed NCT02112539 - Aggreguide A-100 ADP Assay Evaluation N/A
Completed NCT00923988 - Effect of Passive Smoking on Platelet Function and Endothelial Function N/A
Terminated NCT00748371 - Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration Phase 4
Recruiting NCT05702463 - Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II Phase 1
Recruiting NCT04842760 - PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
Withdrawn NCT00942617 - Measurement of Platelet Dense Granule Release in Healthy Volunteers N/A
Recruiting NCT06236243 - Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults N/A
Completed NCT00763997 - Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages N/A
Active, not recruiting NCT03615846 - Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
Completed NCT04369534 - Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction Phase 4
Completed NCT01603966 - Low Dose Aspirin Studied With the AggreGuide N/A
Completed NCT01152229 - Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine N/A
Recruiting NCT03528603 - Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal N/A